QQ客服 官方微博 反馈留言

	The Application Methods of Mitogen-activated Protein Kinase Signal Pathway Inhibitors SP600125 and SB203580 in Long-term in Vivo Experiments
	Cai, H.; Chen, Q.*; Liu, Y.; Xie, H.; Lu, Q.; Chen, X.
刊名	WEST INDIAN MEDICAL JOURNAL
	2018
卷号	67期号:2页码:98-104
关键词	C-Jun N-terminal kinase in vivo mitogen-activated protein kinases p38 SB203580 SP600125
ISSN号	2309-5830
DOI	10.7727/wimj.2015.487
URL标识	查看原文
WOS记录号	WOS:000443901500001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5709383
专题	湖南中医药大学
作者单位	1.[Cai, H. 2.Chen, Q 3.Liu, Y. 4.Xie, H. 5.Chen, X. 6.Chen, Q. 7.Lu, Q.] Hunan Univ Tradit Chinese Med, Affiliated Hosp 1, Changsha 410007, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Cai, H.,Chen, Q.*,Liu, Y.,et al. The Application Methods of Mitogen-activated Protein Kinase Signal Pathway Inhibitors SP600125 and SB203580 in Long-term in Vivo Experiments[J]. WEST INDIAN MEDICAL JOURNAL,2018,67(2):98-104.
APA	Cai, H.,Chen, Q.*,Liu, Y.,Xie, H.,Lu, Q.,&Chen, X..(2018).The Application Methods of Mitogen-activated Protein Kinase Signal Pathway Inhibitors SP600125 and SB203580 in Long-term in Vivo Experiments.WEST INDIAN MEDICAL JOURNAL,67(2),98-104.
MLA	Cai, H.,et al."The Application Methods of Mitogen-activated Protein Kinase Signal Pathway Inhibitors SP600125 and SB203580 in Long-term in Vivo Experiments".WEST INDIAN MEDICAL JOURNAL 67.2(2018):98-104.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。